Paving the way: major study launches to ready STXBP1 treatments for trials
NCT ID NCT06625112
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 28 times
Summary
This study follows 120 people with STXBP1-related disorders—a rare genetic condition causing severe developmental delays and seizures—to better understand how the disease changes over time. Researchers will track symptoms and identify the best ways to measure treatment success, so future therapies can be tested effectively. The goal is to prepare for upcoming precision medicine and gene therapy trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STXBP1 ENCEPHALOPATHY WITH EPILEPSY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universitair Ziekenhuis Antwerpen
RECRUITINGAntwerp, Belgium
Contact
Conditions
Explore the condition pages connected to this study.